Memio company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Incubator/Accelerator | Alive

Total Raised


About Memio

Memio is a mobile messaging service that sends reminders to the elderly when it's time to take their medication.

Memio Headquarter Location

Via Casilina



Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Memio

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Memio is included in 2 Expert Collections, including Pharma Supply Chain.


Pharma Supply Chain

1,258 items


Digital Health

13,075 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Latest Memio News

LUISS ENLABS Acceleration Program H1 2017 – Startup Spotlight: Memio

Mar 6, 2017

LUISS ENLABS Acceleration Program H1 2017 – Startup Spotlight: Memio 06 March 2017 The Batch Winter 2017 of LUISS ENLABS Acceleration Program has started. LVenture Group & LUISS ENLABS will present each startup who has entered it one by one in a "Startup Spotlight". Here's Memio, the startup that reminds the medication Memio is the startup that reminds “the right medication at the right time”. Memiocall, the service offered by Memio, is a tailored reminder service that reminds people to take the right medication at the right time via text or voice messages. It is aimed to people that have to take multiple medications during the day but usually forget. Memio is now entering the B2B sector through a synergic collaboration with clinics and hospitals that will provide directly the memiocall service to their discharged patients free of charge. The startup operates in Digital Health Care sector, which is rapidly growing at the global level, and has a great potential in terms of usefulness of the service provided: every year, 20 million people worldwide are hospitalized because they poorly follow their medical therapies. Only 3 out of 10 patients, after being discharged from the hospital, remember to take medication as prescribed. The team was founded thanks to Innovaction Lab, the national competition for innovative business ideas. Before joining LUISS ENLABS, Memio participated in the Acceleration Program run by Startupbootcamp IoT & Data Tech in Barcelona between 2015 and 2016, and in October 2016 Memio also became part of Unicredit StartLab portfolio. Find out more in the video-interview on Diario Innovazione (Italian Only) Tags: What you can do with us " LVenture Group SpA is among the leading operators of seed Venture Capital in Italy, listed on the MTA of the Italian Stock Exchange. We select and invest in the most promising digital startups.” Via Marsala, 29 H-I - 00185 Roma, Italia Capitale Sociale i.v. : € 8.444.949

  • Where is Memio's headquarters?

    Memio's headquarters is located at Via Casilina, Rome.

  • What is Memio's latest funding round?

    Memio's latest funding round is Incubator/Accelerator.

  • How much did Memio raise?

    Memio raised a total of $20K.

  • Who are the investors of Memio?

    Investors of Memio include LUISS ENLABS and Startupbootcamp.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.